GSK2200150A
CAS No. 1443138-53-1
GSK2200150A( GSK2200150A | GSK-2200150A | GSK 2200150A )
Catalog No. M17300 CAS No. 1443138-53-1
GSK2200150A, identified by high-throughput screening (HTS) campaign, is an anti-tuberculosis (TB) agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 10MG | 36 | In Stock |
|
| 25MG | 69 | In Stock |
|
| 50MG | 110 | In Stock |
|
| 100MG | 164 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGSK2200150A
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK2200150A, identified by high-throughput screening (HTS) campaign, is an anti-tuberculosis (TB) agent.
-
DescriptionGSK2200150A is an antimycobacterial agent against Mycobacterium tuberculosis and Mycobacterium bovis BCG.
-
In VitroGSK2200150A is a novel antimycobacterial agent against Mycobacterium tuberculosis.The activities of GSK2200150A containing the spirocycle core are determined against the virulent M.tuberculosis strain (H37Rv) with MIC of 0.38 μM.
-
In Vivo——
-
SynonymsGSK2200150A | GSK-2200150A | GSK 2200150A
-
PathwayJAK/STAT Signaling
-
TargetPim
-
RecptorBacterial
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number1443138-53-1
-
Formula Weight357.47
-
Molecular FormulaC20H23NO3S
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 83.33 mg/mL. 233.11 mM
-
SMILESC4COC3(CCN(Cc1ccc2OCCOc2c1)CC3)c5ccsc45
-
Chemical Name1-[(2,3-Dihydro-1,4-benzodioxin-6-yl)methyl]-6',7'-dihydro-spiro[piperidine-4,4'-[4H]thieno[3,2-c]pyran]
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.?Badiola KA, et al. Efficient Synthesis and Anti-Tubercular Activity of a Series of Spirocycles: An Exercise in OpenScience. PLoS One. 2014 Dec 10;9(12):e111782.
molnova catalog
related products
-
K00135
K00135 is a selective inhibitor of Pim kinases and can be used in studies about gastric cancer and antileukemic therapeutics.
-
PIM-447 dihydrochlor...
A highly potent and selective inhibitor of pan-Pim with IC50s of 6/18/9 pM for Pim/1/2/3 respectively.
-
Pim-1/2 kinase inhib...
Pim-1/2 Kinase Inhibitor 1, an orally active inhibitor, impedes the action of Pim kinases by preventing their ability to phosphorylate peptides.
Cart
sales@molnova.com